Vaccine for rotavirus seeks approval from the Food and Drug Administration

被引：0

|

作者：

Potera, C

机构：

来源：

GENETIC ENGINEERING NEWS | 1997年 / 17卷 / 21期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：24 / +

相关论文

共 50 条

[21] Product Approval and Public Health at the US Food and Drug Administration
Lurie, Peter
Sharfstein, Joshua M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2469 - 2470
[22] US Food and Drug Administration Revises Recommendations for Rotavirus Vaccines
不详
NEWBORN AND INFANT NURSING REVIEWS, 2010, 10 (04) : E13 - E13
[23] Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
Johnson, John R.
Ning, Yang-Min
Farrell, Ann
Justice, Robert
Keegan, Patricia
Pazdur, Richard
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (08) : 636 - 644
[24] Biogen seeks approval of Alzheimer's drug
Jarvis, Lisa M.
CHEMICAL & ENGINEERING NEWS, 2019, 97 (42) : 10 - 10
[25] The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process
Roden, DM
Temple, R
CIRCULATION, 2005, 111 (13) : 1697 - 1702
[26] United States food and drug administration requirements for approval of generic drug products
Meyer, MC
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 4 - 9
[27] US food and drug administration drug approval summary: Conversion of imatinib mesylate (ST1571; Gleevec) tablets from accelerated approval to full approval
Cohen, MH
Johnson, JR
Pazdur, R
CLINICAL CANCER RESEARCH, 2005, 11 (01) : 12 - 19
[28] United States Food and Drug Administration seeks global regulatory regime
Walkinshaw, Erin
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12) : E777 - E778
[29] Administration seeks to modernize vaccine production
Wechsler, Jill
Pharmaceutical Technology, 2010, 34 (10) : 32 - 38
[30] ADMINISTRATION OF TECLISTAMAB SHORTLY AFTER FOOD AND DRUG ADMINISTRATION APPROVAL IN A COMMUNITY HOSPITAL SYSTEM
Bolton, Deborah
Bana, Alia
Martin, Jaclyn
Monsale, Samuel
ONCOLOGY NURSING FORUM, 2024, 51 (02)

← 1 2 3 4 5 →